IDK
LIVE

Serial Number

79148088

Owner

Immundiagnostik AG

Attorney

GABRIELLE S. ROTH

Filing Date

Mar 27, 2014

Add to watchlist:

No watchlists yet
View on USPTO

IDK Trademark

Serial Number: 79148088 • Registration: 4729633

IDK is a trademark filed by Immundiagnostik AG on March 27, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Immundiagnostik AG (30 trademarks)

Bensheim 64625 , DE

Entity Type: 03

Trademark Details

Filing Date

March 27, 2014

Registration Date

May 5, 2015

Published for Opposition

February 17, 2015

Goods & Services

Chemistry services, namely, services of a chemist; chemical analysis; chemical research; [ water analysis; ] scientific research; scientific laboratory services

Bacteriological preparations, other than for medical or veterinary purposes, namely, bacteria for use in analysis of food and non-clinical samples; [ biological tissue cultures other than for medical or veterinary purposes; biological preparations for the laboratory other than for medical and veterinary purposes, namely, biological tissue cultures; ] chemical preparations for scientific and research purposes, namely, for analyses in laboratories other than for medical and veterinary purposes; chemical preparations for use in science other than for medical and veterinary purposes; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; preparations for in-vitro diagnostics, other than for medical purposes [ ; stem cells, other than for medical and veterinary purposes ]

Pharmaceutical advice; medical and clinic examination services, namely, medical analysis services relating to the treatment of persons [ ; medical and clinic examination services, namely, physical examination services ]

Biological tissue cultures for medical purposes; biological tissue culture for veterinary purposes; [ chemical preparations for pharmaceutical purposes, namely, for treating cardiovascular, gastrointestinal, renal, osseous, degenerative and oncological diseases; chemical preparations for veterinary purposes, namely, for treatment of cardiovascular, gastrointestinal, renal, osseous, degenerative and oncological diseases in mammals; ] chemical reagents for medical and veterinary purposes; diagnostic preparations for medical purposes; enzymes for veterinary purposes; enzymes for medical purposes; in-vitro diagnostic preparations for medical purposes; cultures of microorganisms for medical and veterinary purposes, namely, for diagnostic purposes [ ; pharmaceutical preparations for medical purposes, namely, for the treatment or prevention of cardiovascular, gastrointestinal, renal, osseous, degenerative, immunological, orthomolecular and oncological diseases, as well as conditions related to the skeletal system, fertility, malnutrition, and oxidative stress; veterinary vaccines for mammals, namely, rats, mice, rabbits, dogs, sheep, pigs, donkeys, horses and cows; and veterinary preparations for the treatment or prevention of cardiovascular, gastrointestinal, renal, osseous, degenerative, immunological, orthomolecular and oncological diseases, as well as conditions related to the skeletal system, fertility, malnutrition, and oxidative stress in mammals, namely, rats, mice, rabbits, dogs, sheep, pigs, donkeys, horses and cows ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 31, 2026 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 31, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 31, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 28, 2025 APRE
TEAS SECTION 71 RECEIVED
May 2, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 5, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Feb 23, 2024 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 18, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 7, 2023 INPS
INVALIDATION PROCESSED
Mar 7, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 14, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 14, 2022 NA71
REGISTERED-SEC.71 ACCEPTED
May 14, 2022 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 11, 2022 APRE
TEAS SECTION 71 RECEIVED
Oct 28, 2021 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 5, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 4, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 18, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 1, 2015 FICS
FINAL DISPOSITION PROCESSED
Sep 1, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 5, 2015 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 31, 2015 NREP
REGISTERED-PRINCIPAL REGISTER
May 5, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2015 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Feb 14, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 28, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 28, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 13, 2015 PREV
ASSIGNED TO LIE
Jan 13, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 22, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 22, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 22, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 22, 2014 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 9, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 9, 2014 REAP
REFUSAL PROCESSED BY IB
Jul 22, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 3, 2014 RFCS
REFUSAL PROCESSED BY MPU
Jul 3, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 3, 2014 RFCR
NON-FINAL ACTION WRITTEN
Jul 2, 2014 CNRT
ASSIGNED TO EXAMINER
Jun 30, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 24, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 19, 2014 REPR